Teladoc Health, Inc.
TDOC
$7.68
$0.496.82%
NYSE
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -32.66M | -93.01M | -48.41M | -33.28M | -837.67M |
Total Depreciation and Amortization | 50.60M | 48.28M | 56.09M | 56.00M | 68.09M |
Total Amortization of Deferred Charges | 44.29M | 41.89M | 35.58M | 35.82M | 30.76M |
Total Other Non-Cash Items | 15.75M | 59.25M | 31.90M | 37.20M | 837.09M |
Change in Net Operating Assets | 13.45M | -40.49M | 10.74M | 14.44M | -9.59M |
Cash from Operations | 91.43M | 15.92M | 85.90M | 110.18M | 88.68M |
Capital Expenditure | -1.27M | -2.73M | -6.13M | -1.60M | -1.91M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -694.00K | -64.61M | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -57.73M | -55.93M | -23.51M | -29.55M | -25.84M |
Cash from Investing | -59.70M | -123.27M | -29.64M | -31.15M | -27.75M |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -550.63M | -- | -- | -- | -- |
Issuance of Common Stock | 696.00K | 769.00K | 2.06M | 957.00K | 3.83M |
Repurchase of Common Stock | -- | -- | -- | -176.00K | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | 0.00 | -83.00K | -23.00K |
Cash from Financing | -549.93M | 769.00K | 2.06M | 698.00K | 3.81M |
Foreign Exchange rate Adjustments | 4.49M | 1.59M | -3.86M | 1.76M | -292.00K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -513.71M | -105.00M | 54.46M | 81.48M | 64.45M |